心血管风险轨迹和发展中风和痴呆的风险:台湾的一项基于社区的队列研究
Pei-Chun Chen1,2, Ta-Chen Su3,4,5, Yun-Yu Chen6,7
1National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan.
Neurology
|September 30, 2025
概括
随着时间的推移,心血管疾病 (CVD) 风险的加速增加显著增加了中风和血管痴呆的风险. 监测长期心血管疾病风险轨迹对于预测神经学结果至关重要.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 脑卒中和痴呆症都有共同的心血管风险因素.
- 心血管疾病 (CVD) 风险的纵向变化可能比静态得分更好地反映累积的血管负担.
研究的目的:
- 调查纵向心血管疾病风险轨迹与发展中风和痴呆的风险之间的关联.
主要方法:
- 对2335名台湾成年人 (≥35岁) 进行前性队列研究,没有先前的中风或痴呆.
- 使用Framingham函数在基线和3次随访 (1990-2000) 评估心血管疾病风险.
- 建模了心血管疾病风险轨迹,并与国家健康数据联系起来,以确定发生的中风/痴呆症.
主要成果:
- 在21年内,加速心血管疾病风险轨迹 (29.2%的参与者) 与所有类型的中风和血管痴呆的风险增加有关.
- 与稳定的心血管疾病风险相比,加速增加显示所有中风的HR为1.81和血管痴呆的HR为2.07.
- 较高的基线心血管疾病风险与中风风险相关,但与血管痴呆症的相关性较小.
结论:
- 加快的心血管疾病风险轨迹与中风和血管痴呆的风险增加有关.
- 纵向心血管疾病风险模式可能会影响血管痴呆风险,独立于基线风险水平.
相关概念视频
Dementia
523
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
523
Longitudinal Studies
479
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
479
Coronary Artery Disease I: Introduction
882
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Coronary Artery Disease IV: Preventive Measures
590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
470
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
470
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321


